Cheung LC, Cruickshank MN, Hughes AM, Singh S, Chua G-A, Ford J, Ferrari E, Oommen J, Malinge S, Lock RB, Kees UR, Kotecha RS. Romidepsin enhances the efficacy of cytarabine in vivo, revealing histone deacetylase inhibition as a promising therapeutic strategy for KMT2A-rearranged infant acute lymphoblastic leukemia. Haematologica [Internet]. 2019Jun.30 [cited 2026Nov.11];104(7):e300-e303. Available from: https://haematologica.org/article/view/8985